COLESTID ORANGE GRANULES DIN 02132699
Status: Cancelled Post Market
Holder: PFIZER CANADA ULC
Molecule: COLESTIPOL HYDROCHLORIDE
Available to quote
Health Canada record
| Active ingredient(s) | COLESTIPOL HYDROCHLORIDE 5 G |
|---|---|
| Dosage form | Granules |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AC02 COLESTIPOL |
| Original market date | 31-Dec-1995 |
| Current status date | 02-Apr-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing COLESTIPOL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02132680 | COLESTID TABLETS | PFIZER CANADA ULC | Tablet | COLESTIPOL HYDROCHLORIDE 1 G | Marketed |
| 00642975 | COLESTID GRANULES | PFIZER CANADA ULC | Granules | COLESTIPOL HYDROCHLORIDE 5 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 261 | 2003-09-15 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2107 | 2001-08-24 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 3686 | 1997-12-11 | New Drug Submission (NDS) | |
| 5959 | 1994-09-30 | Supplement to a New Drug Submission (SNDS) | NEW FORMULATION, REVISED PRODUCT MONOGRAPH |
International API supply for COLESTIPOL HYDROCHLORIDE
6 active FDA Drug Master Files.
Request a quote for COLESTID ORANGE GRANULES